Hepatitis C Virus Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 BMY Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-02-25 BMY Fell Below 50 DMA Bearish
2021-02-25 ENTA Fell Below 20 DMA Bearish
2021-02-25 ENTA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 GNMK MACD Bearish Signal Line Cross Bearish
2021-02-25 GNMK Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 GNMK 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 IONS Fell Below 200 DMA Bearish
2021-02-25 NNVC Stochastic Reached Oversold Weakness
2021-02-25 NNVC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 NNVC 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 RGLS Stochastic Reached Oversold Weakness
2021-02-25 RGLS 50 DMA Resistance Bearish
2021-02-25 RGLS New Downtrend Bearish
2021-02-25 SCYX 50 DMA Support Bullish
2021-02-25 SCYX New Downtrend Bearish
2021-02-25 VRTX Fell Below 20 DMA Bearish

Recent News for Hepatitis C Virus Stocks

Date Stock Title
Feb 26 BMY European Medicines Agency's CHMP Backs Approval Of Cabometyx/Opdivo Combo In Kidney Cancer
Feb 26 IONS Ionis Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 26 BMY Bristol Myers' opdivo combo wins positive opinion from EU in kidney cancer
Feb 26 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
Feb 26 GNMK GenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q4 2020 Results - Earnings Call Transcript
Feb 25 INO A Balanced Take on Inovio Pharmaceuticals Stock
Feb 25 GNMK GenMark Diagnostics EPS misses by $0.04, beats on revenue
Feb 25 SCYX SCYNEXIS to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event
Feb 25 GNMK GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
Feb 25 BMY Bluebird bio up after peer-reviewed publication of ide-cel data in multiple myeloma
Feb 24 IONS Ionis Pharmaceuticals, Inc. (IONS) Q4 2020 Earnings Call Transcript
Feb 24 IONS Ionis Pharmaceuticals, Inc. (IONS) CEO Brett Monia on Q4 2020 Results - Earnings Call Transcript
Feb 24 BMY Bristol-Myers receives FDA’s orphan drug designation for multiple myeloma therapy
Feb 24 BMY Here's Why Bristol Myers Squibb Is Making A Mistake With Its Cash
Feb 24 BMY Top 15 Pharmaceutical Companies With Highest R&D Spending
Feb 24 VRTX Vertex to Present at the Cowen Health Care Conference on March 2
Feb 24 INO Qiagen to develop a companion diagnostic for Inovio’s VGX-3100 in cervical dysplasia
Feb 24 BMY Bristol Myers Is Taking Full Advantage of its Celgene Acquisition
Feb 24 INO The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Feb 24 IONS The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO

Hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans.

More about Hepatitis C Virus
Browse All Tags